General MedicationsINJECTIONGeneric

CEFOTAXIME AND DEXTROSE 3.9% IN PLASTIC CONTAINER

CEFOTAXIME SODIUM

Standard Dose

EQ 1GM BASE

Max Dose

Refer to approved labeling

Primary Use

Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview CEFOTAXIME AND DEXTROSE 3.9% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 050792 (NDA).

Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.

Structured Monograph

Clinical summary

Approval overview CEFOTAXIME AND DEXTROSE 3.9% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 050792 (NDA). Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFOTAXIME SODIUM Form and strength INJECTABLE;INJECTION - EQ 1GM BASE Sponsor B BRAUN Submission history Latest submission status date: 2007-09-10 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.